Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nucala
Pharma
GSK revs up launch plans after Nucala's FDA approval in COPD
The thumbs-up makes Nucala the second biologic approved in COPD and the third new therapy cleared for the disease by the FDA in less than a year.
Fraiser Kansteiner
May 22, 2025 3:10pm
FDA misses target date for GSK's Nucala in COPD
May 8, 2025 1:39pm
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
Sep 18, 2024 11:46am
GSK posts COPD win for Nucala as rival nears possible approval
Sep 6, 2024 9:40am
AZ's Fasenra shows comparable efficacy in trial vs. GSK's Nucala
Sep 12, 2023 9:01am
Eisai, Astellas, GSK and more—Fierce Pharma Asia
Jul 21, 2023 8:15am
